(Q42528941)

1 November 2017

Cross-Species Differential Plasma Protein Binding of MBX-102/JNJ39659100: A Novel PPAR-gamma Agonist (English)

1 reference

1 November 2017

Holly J Clarke

1

1 reference

1 November 2017

Francine Gregoire

2

1 reference

1 November 2017

Fang Ma

3

1 reference

1 November 2017

Robert Martin

4

1 reference

1 November 2017

Spring Zhao

5

1 reference

1 November 2017

Brian E Lavan

6

1 reference

1 November 2017

1 January 2008

1 reference

1 November 2017

1 reference

1 November 2017

2008

1 reference

1 November 2017

465715

1 reference

Creative Commons Attribution 3.0 Unported

1 November 2017

start time

1 January 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Long-term effect of halofenate on serum lipids

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Effect of halofenate and clofibrate on lipid synthesis in rat adipocytes

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

The distribution of halofenate in plasma: a comparative analysis using Scatchard vs. stepwise association constants

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Effects of Halofenate on Glucose Tolerance in Patients with Hyperlipoproteinemia

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Potentiation of Hypoglycemic Effect of Chlorpropamide and Phenformin by Halofenate

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Potentiation of Hypoglycemic Effect of Sulfonylureas by Halofenate

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Effect of halofenate on serum uric acid

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Evaluation of highly bound drugs: interspecies, intersubject, and related comparisons

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

Improved Control of Non-insulin-dependent Diabetes Mellitus by Combined Halofenate and Chlorpropamide Therapy

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2535826

A two-year crossover therapeutic trial with halofenate and clofibrate

16 August 2018

1 reference

12 December 2020

Halofenate: an effective hypolipemia- and hypouricemia-inducing drug

1 reference

12 December 2020

Effect of halofenate on serum lipids

1 reference

12 December 2020

The disposition and metabolism of naveglitazar, a peroxisome proliferator-activated receptor alpha-gamma dual, gamma-dominant agonist in mice, rats, and monkeys

1 reference

12 December 2020

Long-term efficacy of halofenate on serum triglyceride levels

1 reference

12 December 2020

Disposition and metabolism of the hypoglycemic agent pioglitazone in rats

1 reference

12 December 2020

Characterizing a drug's primary binding site on albumin

1 reference

12 December 2020

Identifiers

DOI

10.1155/2008/465715

1 reference

1 November 2017

1 reference

1 November 2017

PubMed publication ID

18815616

1 reference